A Business at a Glance
0 of 1 daily views used (1 remaining). Sign up free for +5 more daily views (6 total), or try AAPL for a full preview.
ALBEMARLE CORP
ALB
$13.5B
Mkt Cap
$114.85
-1.76%
ALBEMARLE CORP (ALB) has a 5-year average return on invested capital (ROIC) of 4.0%. This is below average and may indicate limited pricing power.
ALBEMARLE CORP (ALB) has a market capitalization of $13.5B. It is classified as a large-cap stock.
Yes, ALBEMARLE CORP (ALB) pays a dividend with a trailing twelve-month yield of 1.41%.
ALBEMARLE CORP (ALB) operates in the Plastic Materials, Synth Resins & Nonvulcan Elastomers industry, within the Materials sector.
ALBEMARLE CORP (ALB) reported annual revenue of $5.1 billion in its most recent fiscal year, based on SEC EDGAR filings.
ALBEMARLE CORP (ALB) has a net profit margin of -13.2%. The company is currently unprofitable.
ALBEMARLE CORP (ALB) generated $692 million in free cash flow in its most recent fiscal year. Positive free cash flow supports dividends, buybacks, and debt reduction.
Albemarle is a global specialty chemicals company that transforms essential resources into critical ingredients for mobility, energy, connectivity, and health across approximately 70 countries. The company operates three reportable segments: Energy Storage, which develops and manufactures lithium compounds (carbonate, hydroxide, chloride) for batteries, grid storage, and specialty applications; Specialties, which produces bromine-based and lithium-based specialty chemicals for automotive, aerospace, electronics, pharmaceuticals, and food safety; and Ketjen (being divested), which provides refining catalysts and performance catalyst solutions. Albemarle's business model combines vertically integrated mining and conversion operations—sourcing lithium from owned and joint-venture mines including Greenbushes and Wodgina in Australia and the Salar de Atacama in Chile, and bromine from Arkansas and the Dead Sea—with downstream chemical manufacturing and customer-focused technical services. The company competes on product quality, supply reliability, innovation, and customer service in highly competitive global markets characterized by index-based pricing and differentiated offerings. With approximately 7,800 employees across more than 25 production and R&D facilities worldwide, Albemarle serves approximately 1,900 customers and maintains a competitive moat through world-class mineral resources, proprietary process chemistry, and established customer relationships across diverse end markets including grid storage, automotive, aerospace, conventional energy, electronics, construction, agriculture, pharmaceuticals, and medical devices.
【Lithium demand resilience and margin recovery】 Management expects global lithium demand to grow 15%-40% in 2026 driven by stationary storage and electric vehicle adoption, with the company maintaining operational focus on cost discipline and cash generation despite near-term geopolitical supply chain disruptions. Energy storage margins are anticipated to improve into the low 30% range at flat pricing scenarios as the company benefits from completed project ramps at Greenbushes and Wodgina with minimal incremental capital required, while specialties margins are expected to reach the high teens reflecting strong bromine pricing and volume opportunities. The company is targeting an additional $100 million-$150 million in cost and productivity improvements in 2026 through manufacturing optimization and supply chain efficiency, with capital spending expected to remain stable, positioning the business to generate measurably positive free cash flow at current lithium pricing levels. Management remains committed to disciplined capital allocation, deleveraging through proceeds from the Ketjen divestiture, and maintaining investment-grade credit quality while preserving optionality for targeted growth investments in world-class resources.
| Metric | Target | Period |
|---|---|---|
| Specialties net sales | $1.3 billion–$1.5 billion | FY2026 |
| Specialties adjusted EBITDA | $225 million–$275 million | FY2026 |
| Cost and productivity improvements | $100 million–$150 million | FY2026 |
| Capital expenditures | $550 million–$600 million | FY2026 |
| Global lithium demand | 1.8–2.2 million tons | FY2026 |
| Global lithium demand | 2.8–3.6 million tons | FY2030 |
Specialties net sales (FY2026): “we are raising our guidance for net sales to $1.3 billion-$1.5 billion”
Specialties adjusted EBITDA (FY2026): “for adjusted EBITDA to $225 million-$275 million”
Cost and productivity improvements (FY2026): “We are on track to deliver our full year cost and productivity improvements of $100 million-$150 million”
Capital expenditures (FY2026): “We continue to expect full year CapEx of $550 million-$600 million”
Global lithium demand (FY2026): “we are introducing 2026 global lithium demand expectations of 1.8-2.2 million tons, up 15%-40% year-over-year”
Global lithium demand (FY2030): “We are also increasing our 2030 global lithium demand outlook to 2.8-3.6 million tons, up about 10% from our previous range”
Generated solely from the company's own reports listed below — not from third-party data. Hallucination risk is low. · Sources: 10-K, Q4 FY2025 Earnings Call, Q3 FY2025 Earnings Call, Q2 FY2025 Earnings Call, Q1 FY2025 Earnings Call
| Metric | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Revenue | 5.5B | 5.1B | 5.4B | 9.6B | 7.3B | 3.3B |
| Net Income | -400M | -677M | -1.3B | 1.6B | 2.7B | 124M |
| EPS | $-3.40 | $-5.76 | $-11.20 | $13.36 | $22.84 | $1.06 |
| Free Cash Flow | 577M | 692M | -993M | -828M | 646M | -609M |
| ROIC | -1.1% | -5.3% | -10.1% | 13.0% | 15.0% | 7.5% |
| Gross Margin | 18.4% | 13.0% | 1.2% | 12.3% | 42.0% | 30.0% |
| Debt/Equity | 0.19 | 0.51 | 0.43 | 0.55 | 0.61 | 0.70 |
| Dividends/Share | $1.62 | $1.62 | $1.61 | $1.60 | $1.58 | $1.56 |
| Operating Income | -153M | -367M | -1.8B | 252M | 2.5B | 798M |
| Operating Margin | -2.8% | -7.1% | -33.0% | 2.6% | 33.7% | 24.0% |
| ROE | -4.1% | -6.9% | -13.6% | 18.1% | 39.5% | 2.5% |
| Shares Outstanding | 118M | 118M | 118M | 118M | 118M | 117M |
| Metric | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||||
| Revenue | 2.4B | 2.8B | 2.7B | 3.1B | 3.4B | 3.6B | 3.1B | 3.3B | 7.3B | 9.6B | 5.4B | 5.1B | 5.5B |
| Gross Margin | 31.5% | 30.4% | 36.2% | 36.0% | 36.1% | 35.0% | 31.8% | 30.0% | 42.0% | 12.3% | 1.2% | 13.0% | 18.4% |
| R&D | 88M | 89M | 80M | 84M | 70M | 58M | 59M | 54M | 72M | 86M | 87M | 51M | 46M |
| SG&A | 355M | 300M | 354M | 450M | 446M | 533M | 430M | 441M | 524M | 910M | 618M | 550M | 564M |
| EBIT | 271M | 345M | 601M | 572M | 912M | 666M | 506M | 798M | 2.5B | 252M | -1.8B | -367M | -153M |
| Op. Margin | 11.1% | 12.2% | 22.4% | 18.6% | 27.0% | 18.6% | 16.2% | 24.0% | 33.7% | 2.6% | -33.0% | -7.1% | -2.8% |
| Net Income | 133M | 335M | 644M | 55M | 694M | 533M | 376M | 124M | 2.7B | 1.6B | -1.3B | -677M | -400M |
| Net Margin | 5.5% | 11.8% | 24.0% | 1.8% | 20.6% | 14.9% | 12.0% | 3.7% | 36.7% | 16.4% | -24.5% | -13.2% | -7.3% |
| Non-Recurring | 111M | 6.8M | 633M | 17M | 425M | 5.9M | 27M | 299M | -8.4M | 81M | 1.2B | 189M | 35M |
| Returns on Capital | |||||||||||||
| ROIC | 11.0% | 6.9% | 8.0% | 7.1% | 14.4% | 6.2% | 5.5% | 7.5% | 15.0% | 13.0% | -10.1% | -5.3% | -1.1% |
| ROE | 8.9% | 14.5% | 18.3% | 1.5% | 19.1% | 14.2% | 9.2% | 2.5% | 39.5% | 18.1% | -13.6% | -6.9% | -4.1% |
| ROA | 3.0% | 4.5% | 7.2% | 0.7% | 9.0% | 6.1% | 3.7% | 1.2% | 20.4% | 9.3% | -7.5% | -4.1% | -2.6% |
| Cash Flow | |||||||||||||
| Op. Cash Flow | 493M | 361M | 736M | 304M | 546M | 719M | 799M | 344M | 1.9B | 1.3B | 688M | 1.3B | 1.1B |
| Free Cash Flow | 382M | 133M | 539M | -14M | -154M | -132M | -52M | -609M | 646M | -828M | -993M | 692M | 577M |
| Owner Earnings | 375M | 86M | 492M | 88M | 330M | 486M | 544M | 70M | 1.6B | 860M | 67M | 583M | 387M |
| CapEx | 111M | 228M | 197M | 318M | 700M | 852M | 850M | 954M | 1.3B | 2.2B | 1.7B | 590M | 506M |
| Maint. CapEx | 104M | 260M | 226M | 197M | 201M | 213M | 232M | 254M | 301M | 430M | 589M | 659M | 655M |
| Growth CapEx | 7.0M | 0 | 0 | 121M | 499M | 638M | 618M | 700M | 961M | 1.7B | 1.1B | 0 | 0 |
| D&A | 104M | 260M | 226M | 197M | 201M | 213M | 232M | 254M | 301M | 430M | 589M | 659M | 655M |
| CapEx/OCF | 22.4% | 63.1% | 26.7% | 104.5% | 128.2% | 118.4% | 106.5% | 50.0% | 66.1% | 162.4% | 244.3% | 46.0% | 46.7% |
| Capital Allocation | |||||||||||||
| Dividends Paid | 84M | 119M | 135M | 141M | 145M | 152M | 162M | 178M | 184M | 187M | 189M | 191M | 191M |
| Dividend Yield | 2.0% | 2.3% | 1.8% | 1.2% | 1.5% | 2.2% | 1.9% | 0.8% | 0.7% | 0.8% | 1.5% | 2.0% | 1.4% |
| Share Buybacks | 150M | 0 | 0 | 250M | 500M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Buyback Yield | 3.7% | N/A | N/A | 1.9% | 6.6% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 0.0% |
| Stock-Based Comp | 14M | 15M | 17M | 19M | 15M | 20M | 23M | 20M | 30M | 37M | 32M | 40M | 41M |
| Debt Repayment | 6.0M | 2.6B | 1.3B | 778M | 0 | 175M | 250M | 1.2B | 705M | 29M | 112M | 506M | 506M |
| Balance Sheet | |||||||||||||
| Net Debt | 810M | 4.3B | 852M | 1.3B | 1.8B | 3.6B | 4.1B | 3.2B | 3.1B | 4.0B | 2.8B | 3.2B | 792M |
| Cash & Equiv. | 2.5B | 214M | 2.3B | 1.1B | 555M | 613M | 747M | 439M | 1.5B | 890M | 1.2B | 1.6B | 1.1B |
| Long-Term Debt | 2.2B | 3.1B | 2.1B | 1.4B | 1.4B | 2.9B | 2.8B | 2.0B | 3.2B | 3.5B | 3.1B | 3.1B | 1.8B |
| Debt/Equity | 2.43 | 1.37 | 0.82 | 0.66 | 0.67 | 1.07 | 1.15 | 0.70 | 0.61 | 0.55 | 0.43 | 0.51 | 0.19 |
| Interest Coverage | 6.6 | 4.2 | 9.2 | 5.0 | 17.4 | 11.5 | 6.9 | 13.0 | 20.1 | 2.2 | -10.7 | -1.8 | -1.8 |
| Equity | 1.4B | 3.3B | 3.8B | 3.7B | 3.6B | 3.9B | 4.3B | 5.6B | 8.0B | 9.4B | 10.0B | 9.5B | 9.9B |
| Total Assets | 5.2B | 9.6B | 8.2B | 7.8B | 7.6B | 9.9B | 10.5B | 11.0B | 15.5B | 18.3B | 16.6B | 16.4B | 15.1B |
| Total Liabilities | 3.7B | 6.2B | 4.2B | 3.9B | 3.8B | 5.8B | 6.0B | 5.2B | 7.3B | 8.6B | 6.4B | 6.6B | 453M |
| Intangibles | 44M | 384M | 355M | 422M | 386M | 355M | 349M | 309M | 288M | 262M | 231M | 214M | 208M |
| Retained Earnings | 1.4B | 1.6B | 2.1B | 2.0B | 2.6B | 2.9B | 3.2B | 3.1B | 5.6B | 7.0B | 5.5B | 4.6B | 4.8B |
| Working Capital | 2.2B | 214M | 2.2B | 1.3B | 815M | 816M | 404M | 119M | 2.4B | 1.7B | 1.9B | 2.2B | 1.7B |
| Current Assets | 3.3B | 1.8B | 3.3B | 2.5B | 2.0B | 2.2B | 2.2B | 2.0B | 5.2B | 5.2B | 3.8B | 4.0B | 3.3B |
| Current Liabilities | 1.1B | 1.6B | 1.1B | 1.2B | 1.2B | 1.4B | 1.8B | 1.9B | 2.7B | 3.6B | 2.0B | 1.8B | 1.6B |
| Per Share Data | |||||||||||||
| EPS | 1.69 | 3.00 | 5.68 | 0.49 | 6.34 | 5.02 | 3.52 | 1.06 | 22.84 | 13.36 | -11.20 | -5.76 | -3.40 |
| Owner EPS | 4.75 | 0.77 | 4.34 | 0.78 | 3.02 | 4.58 | 5.10 | 0.60 | 13.39 | 7.30 | 0.57 | 4.96 | 3.28 |
| Book Value | 17.23 | 29.15 | 33.49 | 32.83 | 32.77 | 37.02 | 39.98 | 48.21 | 67.78 | 79.92 | 84.77 | 81.07 | 83.56 |
| Cash Flow/Share | 6.24 | 3.23 | 6.49 | 2.72 | 4.99 | 6.77 | 7.48 | 2.95 | 16.20 | 11.26 | 5.85 | 10.90 | 2.16 |
| Dividends/Share | 1.10 | 1.16 | 1.22 | 1.28 | 1.34 | 1.47 | 1.54 | 1.56 | 1.58 | 1.60 | 1.61 | 1.62 | 1.62 |
| Shares Out. | 78.9M | 111.6M | 113.3M | 111.9M | 109.4M | 106.2M | 106.8M | 116.7M | 117.8M | 117.8M | 117.5M | 117.6M | 117.9M |
| Valuation | |||||||||||||
| P/E Ratio | 30.6 | 16.4 | 13.5 | 234.2 | 11.0 | 13.3 | 40.0 | 9.7 | 8.9 | 10.8 | N/A | N/A | -33.8 |
| P/FCF | 10.7 | 41.4 | 16.1 | N/A | N/A | N/A | N/A | N/A | 37.2 | N/A | N/A | 25.4 | 23.5 |
| EV/EBIT | 18.0 | 28.3 | 15.8 | 24.7 | 10.3 | 15.9 | 37.9 | 11.4 | 11.0 | 83.2 | N/A | N/A | N/A |
| Price/Book | 3.0 | 1.7 | 2.3 | 3.5 | 2.1 | 1.8 | 3.5 | 4.6 | 3.0 | 1.8 | 1.0 | 1.8 | 1.4 |
| Price/Sales | 1.7 | 1.8 | 2.7 | 3.7 | 2.9 | 2.0 | 2.8 | 3.0 | 3.7 | 2.3 | 2.3 | 1.9 | 2.5 |
| FCF Yield | 9.4% | 2.4% | 6.2% | -0.1% | -2.0% | -1.9% | -0.3% | -2.3% | 2.7% | -4.9% | -9.8% | 3.9% | 4.3% |
| Market Cap | 4.1B | 5.5B | 8.7B | 12.8B | 7.6B | 7.1B | 15.0B | 26.0B | 24.0B | 16.9B | 10.1B | 17.6B | 13.5B |
| Avg. Price | 54.11 | 46.01 | 64.60 | 102.00 | 89.41 | 66.21 | 81.46 | 184.18 | 227.32 | 188.53 | 104.21 | 81.30 | 114.85 |
| Year-End Price | 51.74 | 49.34 | 76.50 | 114.75 | 69.52 | 66.58 | 140.76 | 220.65 | 204.20 | 143.80 | 86.28 | 149.64 | 114.85 |
ALBEMARLE CORP passes 3 of 9 quality checks, indicating weak fundamentals.
On a free-cash-flow basis, the stock trades at 19.5x vs a median of 25.4x. The company's 5-year average ROIC is 4.0% with a gross margin of 19.7%. Total shareholder yield (dividends) is 1.4%. At current prices, the estimated annualized return to fair value is +22.8%.
ALBEMARLE CORP (ALB) has a debt-to-equity ratio of 0.51. This indicates moderate leverage.
ALBEMARLE CORP (ALB) reported earnings per share (EPS) of $-5.76 in its most recent fiscal year.
ALBEMARLE CORP (ALB) has a return on equity (ROE) of -6.9%. A negative ROE may indicate losses or negative equity.
ALBEMARLE CORP (ALB) has a 5-year average gross margin of 19.7%. This lower margin is typical of capital-intensive or commodity businesses.
The Ledger Terminal provides 18 years of financial data for ALBEMARLE CORP (ALB), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
ALBEMARLE CORP (ALB) has a book value per share of $81.07, based on its most recent annual SEC filing.
Based on recent SEC filings and earnings disclosures, Management expects global lithium demand to grow 15%-40% in 2026 driven by stationary storage and electric vehicle adoption, with the company maintaining operational focus on cost discipline and cash generation despite near-term geopolitical supply chain disruptions. Energy storage margins are anticipated to improve into the low 30% range at flat pricing scenarios as the company benefits from completed project ramps at Greenbushes and Wodgina with minimal incremental capital required, while specialties margins are expected to reach the high teens reflecting strong bromine pricing and volume opportunities. The company is targeting an additional $100 million-$150 million in cost and productivity improvements in 2026 through manufacturing optimization and supply chain efficiency, with capital spending expected to remain stable, positioning the business to generate measurably positive free cash flow at current lithium pricing levels. Management remains committed to disciplined capital allocation, deleveraging through proceeds from the Ketjen divestiture, and maintaining investment-grade credit quality while preserving optionality for targeted growth investments in world-class resources.
Based on recent SEC filings and earnings calls, ALBEMARLE CORP (ALB) has provided the following forward guidance: Specialties net sales: $1.3 billion–$1.5 billion (FY2026); Specialties adjusted EBITDA: $225 million–$275 million (FY2026); Cost and productivity improvements: $100 million–$150 million (FY2026); Capital expenditures: $550 million–$600 million (FY2026); Global lithium demand: 1.8–2.2 million tons (FY2026), plus 1 additional metric.